DCM
ABBV icon

Decade Capital Management’s AbbVie ABBV Stock Holding History

Decade Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-280,000
Closed -$11.6M – 229
2013
Q2 		$11.6M Buy
+280,000
New +$12.2M 0.74% 39

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Decade Capital Management's ABBV Position: Q3 2013 in Review

Decade Capital Management sold out of AbbVie (ABBV) in Q3 2013, closing a stake of 280,000 shares — an estimated $11.6M sold.

Decade Capital Management first reported a position in ABBV in Q2 2013 and held it in 1 quarter. The position peaked at $11.6M in Q2 2013. 1,296 funds tracked by Wall St. Rank hold ABBV as of Q3 2013.

  • Decade Capital Management reported no remaining AbbVie position as of Q3 2013 after selling out during the quarter.
  • Decade Capital Management sold 280,000 AbbVie shares in Q3 2013, an estimated $11.6M.
  • Decade Capital Management first reported a position in AbbVie in Q2 2013 and held it in 1 quarter.
  • Decade Capital Management's AbbVie position peaked at $11.6M in Q2 2013.
  • 1,296 funds tracked by Wall St. Rank held AbbVie as of Q3 2013.

Based on Decade Capital Management's 13F filing for Q3 2013, filed 14 Nov 2013.